Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Guardian Pharmacy Svcs Inc (GRDN)

168 + Investors. Track Smart Money conviction in GRDN. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +41
Streak
7Q ▲
Buyers last Q
65%

Smart Money Signals — GRDN

Based on 168 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 7 quarters in a row

last 6Q
For 7 consecutive quarters, more hedge funds added GRDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
168 hedge funds hold GRDN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +127% more funds vs a year ago

fund count last 6Q
+94 new funds entered over the past year (+127% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 65% buying

108 buying57 selling
Last quarter: 108 funds were net buyers (56 opened a brand new position + 52 added to an existing one). Only 57 were sellers (42 trimmed + 15 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+23 vs last Q)

new funds entering per quarter
Funds opening a new GRDN position: 35 → 23 → 33 → 56. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 51% entered in last year

■ 3% conviction (2yr+) ■ 46% medium ■ 51% new
Only 5 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +61% but shares only +42% — price-driven

Value
+61%
Shares
+41%
Last quarter: the total dollar value of institutional holdings rose +61%, but actual share count only changed +42%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

15 → 35 → 23 → 33 → 56 new funds/Q
New funds entering each quarter: 35 → 23 → 33 → 56. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🌱

Early stage — 63% of holders entered in last year

■ 5% veterans ■ 32% 1-2yr ■ 63% new
Of 169 current holders: 107 (63%) entered in the past year, only 8 (5%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
✅

Strong quality — 37% AUM from major funds

37% from top-100 AUM funds
45 of 168 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.3
out of 10
Moderate Exit Risk
Exit risk score 5.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — GRDN

In 2026 Q1, 108 hedge funds were net buyers of GRDN (56 opened a new position, 52 added to an existing one), while 57 reduced or exited (42 trimmed, 15 sold completely) — a 65% buyer ratio, indicating clear institutional accumulation. This marks 7 consecutive quarters of net institutional buying — a persistent conviction signal. 37% of total institutional value in GRDN is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +41 funds (more new holders than closures). Total institutional holders: 168.

Hedge Fund Ownership: GRDN

How many hedge funds hold GRDN — quarterly history vs. share price
Quarterly hedge fund ownership of GRDN vs. share price

Market Analysis: GRDN

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GRDN

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Guardian Pharmacy Svcs Inc (GRDN) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much GRDN has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
GRDN
+16.5%
XLV
+4.5%

GRDN outperformed XLV by +12.0% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
GRDN
+19.8%
XLV
+5.6%

Since the filing became public, GRDN outperformed XLV by +14.2% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

21 top-rated funds 1 high-conviction
Consensus
5.8
/ 10
breadth
×
Elite
1.8
/ 10
conviction
Hedge Fund Positioning: GRDN
168 + Investors

Track Smart Money conviction in GRDN. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 168 127 32.28%
13F Shares 28M 20M 41.6%
Total Value $969M $601M 61.35%
New Positions 56 33 +23
Increased Positions 52 51 +1
Closed Positions 15 17 -2
Reduced Positions 42 32 +10
Total Calls 0 0 -
Total Puts 1 1 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: GRDN

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

168 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GRDN. Verified SEC 13F-HR filings.

QUARTER:
Top 25 GRDN holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Boone Capital Management LLC 7.28% 631,193 $23.8M
2 Valiant Capital Management, L.P. 2.57% 1,186,658 $44.7M
3 Lisanti Capital Growth, LLC 1.79% 188,150 $7.1M
4 Aristotle Capital Boston, LLC 1.16% 495,856 $18.7M
5 Kiker Wealth Management, LLC 1.03% 57,027 $2.1M
6 Seven Grand Managers, LLC 0.50% 200,000 $7.5M
7 Ranger Investment Management, L.P. 0.46% 167,190 $6.3M
8 Peregrine Capital Management LLC 0.28% 201,603 $7.6M
9 Globeflex Capital L P 0.25% 44,354 $1.7M
10 Legato Capital Management LLC 0.20% 58,890 $2.2M
11 Woodline Partners LP 0.19% 1,306,318 $49.2M
12 J. Goldman & Co LP 0.17% 159,572 $6.0M
13 Hussman Strategic Advisors, INC. 0.17% 21,000 $791K
14 Driehaus Capital Management LLC 0.16% 589,121 $22.2M
15 Inspire Investing, LLC 0.15% 49,565 $1.9M
16 Ghisallo Capital Management LLC 0.13% 125,000 $4.7M
17 EntryPoint Capital, LLC 0.11% 9,537 $359K
18 Silvercrest Asset Management Group LLC 0.10% 374,946 $14.1M
19 Brown Advisory Inc 0.08% 1,259,174 $47.4M
20 Dark Forest Capital Management LP 0.08% 22,978 $865K
21 Round Rock Advisors LLC 0.07% 11,795 $444K
22 Loomis Sayles & Co L P 0.05% 931,689 $35.1M
23 Trexquant Investment LP 0.04% 163,020 $6.1M
24 Mangrove Partners IM, LLC 0.04% 13,249 $499K
25 Boston Partners 0.04% 1,017,683 $38.4M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Guardian Pharmacy Svcs Inc (GRDN)

What does the Smart Money Trend signal show for GRDN?

Buying streak — 7 quarters in a row: For 7 consecutive quarters, more hedge funds added GRDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for GRDN?

More buyers than sellers — 65% buying: Last quarter: 108 funds were net buyers (56 opened a brand new position + 52 added to an existing one). Only 57 were sellers (42 trimmed + 15 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for GRDN holders?

Strong quality — 37% AUM from major funds: 45 of 168 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held GRDN?

Mostly new holders — 51% entered in last year: Only 5 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Guardian Pharmacy Svcs Inc (GRDN) following the 2026 Q1 hedge fund 13F filings?

As of today, GRDN has moved +19.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.6% for the XLV sector ETF — an outperformance of +14.2%. Since the quarter end (March 31, 2026), GRDN has gained +16.5% vs +4.5% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →